Rating History for Anadys Pharmaceuticals (ANDS) by Noble Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/18/2011 N/A Downgrade Underperform
(N/A)
3.50
(N/A)
3.65
(3.70)
1.37% Details